Liver, Renal, and Cardiovascular Failure After Unintentional Overdose of Tizanidine in a 2-Year-Old Child

Insights

Tizanidine overdose in a child with spastic quadriplegia caused severe liver, kidney, and cardiovascular failure. This case highlights the risks of high-dose tizanidine in pediatric patients, especially with comorbidities and dehydration.

Area of Science:

  • Pharmacology
  • Pediatric Critical Care
  • Toxicology

Background:

  • Tizanidine, an alpha-2 adrenergic agonist, is approved for adult spasticity but used off-label in pediatrics.
  • Gradual dose titration is standard in adults; however, overdose risks in children are less understood.
  • Comorbidities like spastic quadriplegia and dysphagia can complicate pediatric treatment.

Purpose of the Study:

  • To report a case of severe tizanidine overdose in a pediatric patient.
  • To highlight the potential for serious organ dysfunction following accidental high-dose tizanidine administration in children.
  • To emphasize the importance of careful dosing and monitoring in pediatric patients with spasticity.

Main Methods:

  • Case report of a 2-year-old male with spastic quadriplegia and dysphagia.
  • Documented accidental overdose of tizanidine (1.6 mg/kg/day) after clonazepam withdrawal and nasogastric tube dislodgement.
  • Clinical presentation, laboratory findings (hepatic and renal dysfunction), and supportive treatment in the pediatric intensive care unit were analyzed.

Main Results:

  • The patient presented with hemodynamic instability, altered consciousness, and severe dehydration.
  • Blood tests indicated significant hepatic and renal dysfunction.
  • Diagnosis was liver, renal, and cardiovascular failure secondary to tizanidine overdose, exacerbated by dehydration.

Conclusions:

  • Tizanidine overdose can lead to critical organ failure in pediatric patients.
  • Dehydration and underlying comorbidities significantly worsen the outcomes of tizanidine overdose.
  • This case underscores the need for cautious tizanidine use and close monitoring in the pediatric population.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
46
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
540
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
196